Evidence check: Glukose in the context of weight loss

The role of glucose in weight loss is complex and often oversimplified. In the short term, reducing carbohydrate intake lowers blood glucose and insulin levels, which can enhance fat oxidation. However, long-term weight loss is primarily driven by energy balance. Continuous glucose monitors (CGMs) are increasingly marketed to non-diabetics to avoid 'glucose spikes' and improve weight loss. The scientific evidence for this is weak: most studies are small, short-term, and show only modest effects, often attributable to behavioral changes (e.g., increased activity, mindful eating) rather than the monitoring itself. Genetic variants affecting glucose metabolism (e.g., in TCF7L2, GCK) have moderate effects on diabetes risk, but their utility for personalized weight-loss diets is unproven. MyBody-X tests may report such variants, but clinical relevance for weight loss remains unclear. Bottom line: glucose monitoring can serve as a motivational tool but does not replace caloric deficit. The evidence is mixed and heavily influenced by marketing.